Real-World Outcomes in Adult Sickle Cell Disease Patients Treated with Crizanlizumab, Voxelotor or Both
| Autor: | Baruwa Etti, Abisola *, Kuo, Chia-ling *, Da Cunha Godoy, Lucas *, Andemariam, Biree |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:8292-8293 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|